108 related articles for article (PubMed ID: 28980157)
1. Expression of the Cholecystokinin-B Receptor in Neoplastic Gastric Cells.
Mjønes P; Nordrum IS; Sørdal Ø; Sagatun L; Fossmark R; Sandvik A; Waldum HL
Horm Cancer; 2018 Feb; 9(1):40-54. PubMed ID: 28980157
[TBL] [Abstract][Full Text] [Related]
2. Netazepide Inhibits Expression of Pappalysin 2 in Type 1 Gastric Neuroendocrine Tumors.
Lloyd KA; Parsons BN; Burkitt MD; Moore AR; Papoutsopoulou S; Boyce M; Duckworth CA; Exarchou K; Howes N; Rainbow L; Fang Y; Oxvig C; Dodd S; Varro A; Hall N; Pritchard DM
Cell Mol Gastroenterol Hepatol; 2020; 10(1):113-132. PubMed ID: 32004755
[TBL] [Abstract][Full Text] [Related]
3. Current understanding of pathogenetic mechanisms in neuroendocrine neoplasms.
Modica R; Liccardi A; Minotta R; Cannavale G; Benevento E; Colao A
Expert Rev Endocrinol Metab; 2024; 19(1):49-61. PubMed ID: 37936421
[TBL] [Abstract][Full Text] [Related]
4. Deterioration of apatite orientation in the cholecystokinin B receptor gene (Cckbr)-deficient mouse femurs.
Mihara Y; Ishimoto T; Ozasa R; Omura T; Yamato Y; Yamada T; Okamoto A; Matsuyama Y; Nakano T
J Bone Miner Metab; 2023 Nov; 41(6):752-759. PubMed ID: 37676507
[TBL] [Abstract][Full Text] [Related]
5. Development of a time-resolved fluorescence probe for evaluation of competitive binding to the cholecystokinin 2 receptor.
Elshan NG; Jayasundera T; Weber CS; Lynch RM; Mash EA
Bioorg Med Chem; 2015 Apr; 23(8):1841-8. PubMed ID: 25769518
[TBL] [Abstract][Full Text] [Related]
6. Analyses of repeated failures in cancer therapy for solid tumors: poor tumor-selective drug delivery, low therapeutic efficacy and unsustainable costs.
Maeda H; Khatami M
Clin Transl Med; 2018 Mar; 7(1):11. PubMed ID: 29541939
[TBL] [Abstract][Full Text] [Related]
7. Correctly identifying the cells of origin is essential for tailoring treatment and understanding the emergence of cancer stem cells and late metastases.
Waldum H; Slupphaug G
Front Oncol; 2024; 14():1369907. PubMed ID: 38660133
[TBL] [Abstract][Full Text] [Related]
8. Elevated Serum Gastrin Is Associated with Melanoma Progression: Putative Role in Increased Migration and Invasion of Melanoma Cells.
Varga AJ; Nemeth IB; Kemeny L; Varga J; Tiszlavicz L; Kumar D; Dodd S; Simpson AWM; Buknicz T; Beynon R; Simpson D; Krenacs T; Dockray GJ; Varro A
Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069171
[TBL] [Abstract][Full Text] [Related]
9. The central role of gastrin in gastric cancer.
Waldum H; Mjønes P
Front Oncol; 2023; 13():1176673. PubMed ID: 37941554
[TBL] [Abstract][Full Text] [Related]
10. Inflammation and Digestive Cancer.
Waldum H; Fossmark R
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686307
[TBL] [Abstract][Full Text] [Related]
11. Gastrin: From Physiology to Gastrointestinal Malignancies.
Duan S; Rico K; Merchant JL
Function (Oxf); 2022; 3(1):zqab062. PubMed ID: 35330921
[TBL] [Abstract][Full Text] [Related]
12. Gastrin/CCK-B Receptor Signaling Promotes Cell Invasion and Metastasis by Upregulating MMP-2 and VEGF Expression in Gastric Cancer.
Zhao Y; Wang Q; Zeng Y; Xie Y; Zhou J
J Cancer; 2022; 13(1):134-145. PubMed ID: 34976177
[TBL] [Abstract][Full Text] [Related]
13. Time to Classify Tumours of the Stomach and the Kidneys According to Cell of Origin.
Waldum H; Mjønes P
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948181
[TBL] [Abstract][Full Text] [Related]
14. Tumor Classification Should Be Based on Biology and Not Consensus: Re-Defining Tumors Based on Biology May Accelerate Progress, An Experience of Gastric Cancer.
Waldum H
Cancers (Basel); 2021 Jun; 13(13):. PubMed ID: 34202596
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic and therapeutic potencies of miR-18a-5p in mixed-type gastric adenocarcinoma.
Wang L; Zhang M; Wang J; Zhang J
J Cell Biochem; 2021 May; 122(9):1062-71. PubMed ID: 33942935
[TBL] [Abstract][Full Text] [Related]
16. The Diagnostic Value of Serum Gastrin-17 and Pepsinogen for Gastric Cancer Screening in Eastern China.
Shen H; Xiong K; Wu X; Cheng S; Lou Q; Jin H; Zhang X
Gastroenterol Res Pract; 2021; 2021():6894248. PubMed ID: 33936196
[TBL] [Abstract][Full Text] [Related]
17. Towards Understanding of Gastric Cancer Based upon Physiological Role of Gastrin and ECL Cells.
Waldum H; Mjønes P
Cancers (Basel); 2020 Nov; 12(11):. PubMed ID: 33266504
[TBL] [Abstract][Full Text] [Related]
18. Correct Identification of Cell of Origin May Explain Many Aspects of Cancer: The Role of Neuroendocrine Cells as Exemplified from the Stomach.
Waldum H; Mjønes PG
Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32796591
[TBL] [Abstract][Full Text] [Related]
19. The Enterochromaffin-like [ECL] Cell-Central in Gastric Physiology and Pathology.
Waldum HL; Sørdal ØF; Mjønes PG
Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31108898
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
